Kingsley Napley advises Harwell Campus on development, lease arrangement, and construction for Moderna
Moderna, a biotechnology business developing mRNA treatments and vaccines, chose Harwell for its Moderna Innovation and Technology Centre (MITC).
The MITC expansion will include a research, development, and manufacturing facility that will offer cutting-edge mRNA vaccines for a variety of respiratory disorders to the UK public, pending regulatory approval. A Northumberland-built modular clinical biomarker laboratory will be put at the MITC.
Peter Metcalfe, Partner
The Kingsley Napley team was led by Partner Peter Metcalfe and Associate Cameron Mason (Construction).
Peter said: “We are delighted to support our long standing client, Harwell Campus, on this ground breaking development and all of the associated construction work streams. We wish Harwell Campus and their contractor, Glencar Construction, the best of luck during the construction phase.”
Cameron Mason, Associate
For detailed information, as well as the picture copyright, please see the law firm’s original article here: Kingsley Napley advises Harwell Campus on development, agreement for lease and construction for Moderna.
